共 169 条
[1]
Peleg AY(2008)Acinetobacter baumannii: emergence of a successful pathogen Clin Microbiol Rev 21 538-582
[2]
Seifert H(2008)Current control and treatment of multidrug-resistant Acinetobacter baumannii infections Lancet Infect Dis 8 751-762
[3]
Paterson DL(2010)Multiresistant Acinetobacter baumannii infections: epidemiology and management Curr Opin Infect Dis 23 332-339
[4]
Karageorgopoulos DE(2012)Colistin: new lessons on an old antibiotic Clin Microbiol Infect 18 18-29
[5]
Falagas ME(2015)Adverse reactions associated with systemic polymyxin therapy Pharmacotherapy 35 28-33
[6]
Garnacho-Montero J(2016)Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis Int J Antimicrob Agents 47 107-116
[7]
Amaya-Villar R(2012)Plant-derived antimicrobial compounds: alternatives to antibiotics Future Microbiol 7 979-990
[8]
Yahav D(2010)Screening of herbal extracts against multi-drug resistant Acinetobacter baumannii Phytotherapy research: PTR 24 1202-1206
[9]
Farbman L(2016)Screening of herbal-based bioactive extract against Carbapenem-resistant strain of Acinetobacter baumannii Microbial drug resistance (Larchmont, NY) 22 364-371
[10]
Leibovici L(2017)Polyvinylpyrrolidone-capped silver nanoparticle inhibits infection of Carbapenem-resistant strain of Acinetobacter baumannii in the human pulmonary epithelial cell Front Immunol 8 973-351